Abstract
BackgroundPsoriasis patients developing psoriatic arthritis (PsA) are thought to go through different phases. Understanding the underlying events in these phases is crucial to diagnose PsA early. Here, we have characterized the circulating memory T helper (Th) cells in psoriasis patients with or without arthralgia, psoriasis patients who developed PsA during follow-up (subclinical PsA), early PsA patients and healthy controls to elucidate their role in PsA development.MethodsWe used peripheral blood mononuclear cells of sex and age-matched psoriasis patients included in Rotterdam Joint Skin study (n=22), early PsA patients included in Dutch South West Early Psoriatic Arthritis Cohort (DEPAR) (n=23) and healthy controls (HC; n=17). We profiled memory Th cell subsets with flow cytometry and used the machine learning algorithm FlowSOM to interpret the data.ResultsThree of the 22 psoriasis patients developed PsA during 2-year follow-up. FlowSOM identified 12 clusters of memory Th cells, including Th1, Th2, Th17/22, and Th17.1 cells. All psoriasis and PsA patients had higher numbers of Th17/22 than healthy controls. Psoriasis patients without arthralgia had lower numbers of CCR6-CCR4+CXCR3+ memory Th cells and higher numbers of CCR6+CCR4-CXCR3-memory Th cells compared to HC. PsA patients had higher numbers of Th2 cells and CCR6+CCR4+CXCR3- cells, but lower numbers of CCR6+CCR4+CXCR3+ memory Th cells compared to HC. The number of CCR6+ Th17.1 cells negatively correlated with tender joint counts and the number of CCR6+ Th17 cells positively correlated with skin disease severity.ConclusionsUnsupervised clustering analysis revealed differences in circulating memory Th cells between psoriasis and PsA patients compared to HC; however, no specific subset was identified characterizing subclinical PsA patients.
Highlights
Psoriatic arthritis (PsA) is a multifaceted chronic rheumatic disease characterized by psoriatic skin lesions, arthritis, enthesitis, dactylitis, and/or axial disease
Twelve of the 22 psoriasis patients had no arthralgia at baseline, and two of these patients received a psoriatic arthritis (PsA) diagnosis in the following 2 years
Total frequencies of memory T helper cells and regulatory T cells do not differ between patients and healthy controls Before using the machine learning algorithm FlowSOM, we manually gated the total frequency of memory Th cells and Regulatory T cell (Treg) cells to determine differences between patients and healthy controls
Summary
Psoriatic arthritis (PsA) is a multifaceted chronic rheumatic disease characterized by psoriatic skin lesions, arthritis, enthesitis, dactylitis, and/or axial disease. Whether all psoriasis patients developing PsA undergo all of these phases is unclear, and the exact triggers and events underlying the transition from one phase to another are not identified yet. Different CD4+CD45RO+ T helper cell subsets, including IL-17A producing cells, can be identified based on differential surface expression of chemokine receptors CD25, CCR6, CCR4, CXCR3, and CCR10: Th1 (CCR6-CD25-/lowCCR4-. We have characterized the circulating memory T helper (Th) cells in psoriasis patients with or without arthralgia, psoriasis patients who developed PsA during follow-up (subclinical PsA), early PsA patients and healthy controls to elucidate their role in PsA development
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.